breast cancer: extended adjuvant therapy and cost factors
Published 6 years ago • 83 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
10:02
breast cancer: extended adjuvant endocrine therapy
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
6:55
extended adjuvant therapy for her2 early breast cancer
-
1:18
dr. graff on extended adjuvant therapy in early-stage hr breast cancer
-
5:16
factors influencing adjuvant therapy use for her2 breast cancer
-
1:56
exploring extended adjuvant endocrine therapy for hr breast cancer
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer
-
0:51
dr. hamilton on extended adjuvant therapy for her2 breast cancer
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
6:47
extended adjuvant therapy for her2-positive early breast cancer
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
3:58
post-adjuvant therapy for her2 breast cancer
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
1:13
dr. mamounas on the role of extended adjuvant endocrine therapy in er breast cancer
-
10:35
compass talks: lucy langer, md --- extended adjuvant therapy in er and breast cancer.
-
5:08
adjuvant therapy for breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
2:46
eleanor: observing real-life extended adjuvant therapy with neratinib and concurrent use of conkado